Status: Recruiting
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
This study is being conducted to evaluate the safety and effectiveness of VBI-S in elevating the blood pressure of septic shock patients with absolute or relative hypovolemia.
Participants needed: 46
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Vivacelle BioUpdated: Apr 4, 2025Locations: 6
Eligibility criteria
Male or female at least 18 years of age. [+15]
Patients with a ventricular assist device [+13]